About: COVID 19: a clue from innate immunity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID 19: a clue from innate immunity Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID 19: a clue from innate immunity
Creator	Moscato, Paolo Quartuccio, Luca Triggiani, Massimo Amato, Patrizia Benucci, Maurizio Birra, Domenico Landolfi, Luigi Licata, Gaetano Loi, Gabriella Merchionda, Anna
Source	Medline; PMC
abstract	The recent COVID-19 pandemic has had a significant impact on our lives and has rapidly expanded to reach more than 4 million cases worldwide by May 2020. These cases are characterized by extreme variability, from a mild or asymptomatic form lasting for a few days up to severe forms of interstitial pneumonia that may require ventilatory therapy and can lead to patient death. Several hypotheses have been drawn up to understand the role of the interaction between the infectious agent and the immune system in the development of the disease and the most severe forms; the role of the cytokine storm seems important. Innate immunity, as one of the first elements of guest interaction with different infectious agents, could play an important role in the development of the cytokine storm and be responsible for boosting more severe forms. Therefore, it seems important to study also this important arm of the immune system to adequately understand the pathogenesis of the disease. Research on this topic is also needed to develop therapeutic strategies for treatment of this disease.
has issue date	2020-06-10(xsd:dateTime)
bibo:doi	10.1007/s12026-020-09137-5
bibo:pmid	32524333
has license	no-cc
sha1sum (hex)	0d2a8b354a49112809d19645963cbca013c90c75
schema:url	https://doi.org/10.1007/s12026-020-09137-5
resource representing a document's title	COVID 19: a clue from innate immunity
has PubMed Central identifier	PMC7286633
has PubMed identifier	32524333
schema:publication	Immunol Res
resource representing a document's body	covid:0d2a8b354a49112809d19645963cbca013c90c75#body_text
is schema:about of	named entity 'extreme' named entity 'interstitial pneumonia' named entity 'lead' named entity 'asymptomatic' named entity 'May 2020' named entity 'IFNα' named entity 'coronaviruses' named entity 'interferon α' named entity 'multiprotein complex' named entity 'TLR' named entity 'tocilizumab' named entity 'TLR' named entity 'IFN gamma' named entity 'fibrinogen' named entity 'TNF-a' named entity 'PMN' named entity 'TIR' named entity 'viral genome' named entity 'cytokines' named entity 'type I interferons' named entity 'IFN' named entity 'IFN' named entity 'SARS-CoV-2' named entity 'IP-10' named entity 'TLR3' named entity 'coronavirus infections' named entity 'chemokines' named entity 'TLR' named entity 'Tocilizumab' named entity 'leukocytosis' named entity 'TLR7' named entity 'receptor' named entity 'human monoclonal antibody' named entity 'viruses' named entity 'IL1' named entity 'cell disruption' named entity 'nsp3' named entity 'COVID-19' named entity 'TLR7' named entity 'complement' named entity 'mice' named entity 'disrupt cell membranes' named entity 'adaptive immune responses' named entity 'randomized clinical trial' named entity 'humanized monoclonal antibody' named entity 'Eculizumab' named entity 'neutrophils' named entity 'coronavirus infection' named entity 'Interferons' named entity 'coronaviruses' named entity 'complement' named entity 'protein' named entity 'dendritic cells' named entity 'autopsies' named entity 'epithelialization' named entity 'IL6' named entity 'MERS-CoV' named entity 'COVID-19' named entity 'transcription' named entity 'Wuhan' named entity 'MAPK' named entity 'transcription factors' named entity 'programmed cell death' named entity 'virus' named entity 'RNA' named entity 'neutrophils' named entity 'coronavirus' named entity 'adaptive immunity' named entity 'phenotype' named entity 'TLR3' named entity 'C5a' named entity 'SpO2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software